Our results indicating augmented renal and peripheral vascular resistance in Cyp1a1-Ren-2 transgenic rats might suggest that prohypertensive actions of 20-HETE and its interaction with RAS importantly contribute to the pathophysiology of malignant hypertension in this model [33,43,44]. Here, CYP1A1 is linked to malignant hypertension.